BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

UAE Approves LEQEMBI® for Early Alzheimer’s Treatment, Marking a Milestone in Regional Healthcare

Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-so...

August 14, 2024 | News

Pulnovo Medical Launches Asia's First International Clinical Study on PADN at Singapore's National Heart Centre

Pulnovo Medical Limited,a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce...

August 10, 2024 | News

WuXi Biologics and Medigene Forge Strategic Partnership to Advance TCR-Guided T Cell Engagers for Cancer Treatment

Partnership leverages Medigene's leadership for T cell receptor (TCR) generation and characterization and WuXi Biologics' unique anti-CD3 mAb, its T cell...

August 09, 2024 | News

Beckman Coulter Life Sciences and Illumina Launch Automated Solution for Faster, Comprehensive Oncology Genomic Profiling

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA...

August 07, 2024 | News

Senhwa Biosciences Receives FDA Green Light for Phase I/II Trial of Silmitasertib in Pediatric Relapsed Refractory Solid Tumors

Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious disea...

August 07, 2024 | News

Leica Microsystems Launches AI-Powered Mateo FL for Advanced Cell Culture Research

Leica Microsystems, a leader in microscopy and scientific instrumentation, has released Mateo FL, an AI-powered digital fluorescence microscope for cell cu...

August 06, 2024 | News

Oxford Nanopore Partners with Singapore's NPM to Map Genomic Diversity of Major Ethnic Groups

Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore's National Precision Medicine (NPM) programme, led by Precis...

August 05, 2024 | News

Bayer Submits New Drug Application to FDA for Elinzanetant, a Novel Non-Hormonal Treatment for Menopausal Hot Flashes

The New Drug Application (NDA) includes data from the Phase III studies OASIS 1, 2 and 3 - showing elinzanetant significantly reduced the frequency...

August 02, 2024 | News

Biosyngen and A*STAR Forge Strategic Alliance to Advance Autoimmune Therapies

Biosyngen has announced a strategic collaboration with Singapore's Agency for Science, Technology and Research (A*STAR) to enhance autoimmune the...

August 02, 2024 | News

Sirnaomics Forms Joint Venture with Gore Range Capital to Propel RNAi Therapeutics into Aesthetic Medicine

Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical co...

August 01, 2024 | News

SCRI and CADENCE Partner with Clinical Research Malaysia to Strengthen Clinical Research in Singapore and Malaysia

The Singapore Clinical Research Institute (SCRI), together with its sister programme, the Cardiovascular Disease National Collaborative Enterprise (CADENCE...

July 31, 2024 | News

NCCN Enhances Partnership with Medlive to Expand Oncology Guidelines Access in China

United States-based National Comprehensive Cancer Network strengthens relationship with Chinese medical platform Medlive to broaden access to eminent oncol...

July 31, 2024 | News

Menarini Group Announces Positive Phase 3 Trial Results for Obicetrapib in Lowering LDL-C

-- Achieved primary endpoint of LS mean reduction in LDL-C on top of maximally tolerated lipid modifying therapies at week 12 with statistically ...

July 30, 2024 | News

Akeso's Ivonescimab sBLA Accepted by NMPA for First-Line Treatment of PD-L1 Positive NSCLC

Akeso (9926.HK) is delighted to announce that the supplemental biologics license application (sBLA) for its independently developed, world's first-in-class...

July 30, 2024 | News

Stay Connected